All results
62 results for tests
-
1305-0023 (FIBRONEERTM ILD)
This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity
AB-101 is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of the immune system and…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Pts w/ MIBC
The purpose of this study is to evaluate the anti-tumor effects of TAR-200 in combination with intravenous (IV) cetrelimab and IV cetrelimab alone. Bladder…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ACTIV-4d or Novel Experimental COVID Therapies Affecting Host Response (NECTAR)
The overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19. Therapeutic goals for patients…
- Ages
- 18 Years - N/A
- Sexes
- All
-
ARGX-113-2007
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)
The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Atacicept in Subjects With IgA Nephropathy
A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3) This is a multi-part study comprising of the original Phase 2b study (active, no…
- Ages
- 18 Years - N/A
- Sexes
- All
-
BIIB059
In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study…
- Ages
- 18 Years - N/A
- Sexes
- All